pseudoephedrine/loratadine (OTC)

Brand and Other Names:Alavert Allergy & Sinus D, Claritin D, more...ChlorTripolon, Alavert D-12, Claritin D-24 Hour
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

pseudoephedrine/loratadine

tablet, extended release

  • 5mg/120mg
  • 10mg/240mg
more...

Allergic Rhinitis/Nasal Congestion

Immediate release: 1 tablet PO q12hr

Extended release: 1 tablet PO qDay

Administration

Tablet should be swallowed whole & not broken, dissolved or chewed

Claritin-D extended release to be taken with a full glass of water

Dosage Forms & Strengths

pseudoephedrine/loratadine

tablet, extended release

  • 5mg/120mg
  • 10mg/240mg
more...

Allergic Rhinitis/Nasal Congestion

<12 years old

  • Safety & efficacy not established

>12 years old

  • Immediate release: 1 tablet PO q12hr
  • Extended release: 1 tablet PO qDay
Next:

Interactions

Interaction Checker

and pseudoephedrine/loratadine

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 
            Previous
            Next:

            Warnings

            Contraindications

            Documented hypersensitivity

            Lower respiratory disease, eg, asthma (controversial)

            Preemies & neonates

            Nursing women

            Concurrent or within 2 wk of MAO inhibitor use

            Hepatic impairment

            Cautions

            Caution in renal impairment, heart disease, BPH, hypertension, diabetes, glaucoma, thyroid dysfunction

            Pregnancy/lactation

            Previous
            Next:

            Pregnancy & Lactation

            Pregnancy Category: B

            Lactation: both drugs pass into breast milk, pseuoephedrine is concentrated in breast milk; use caution

            Pregnancy Categories

            A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

            B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

            C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

            D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

            X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

            NA:Information not available.

            more...
            Previous
            Next:

            Images

            Previous
            Next: